Back to Trials
NCT02432092Recruiting

Pediatric Cardiomyopathy Mutation Analysis

Indiana University

Start Date

4/1/2014

Completion Date

12/31/2030

Summary

The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abnormal cardiac function.

Detailed Description

Cardiomyopathy is a genetically heterogeneous heart muscle disorder that results in ventricular dysfunction. While significant progress has been made in identifying the genetic basis of cardiomyopathy in adults, molecular diagnosis in children has proven more challenging and current algorithms do not incorporate mutation analysis in the clinical protocol. However, recent studies indicate that cardiomyopathy outcomes in children are origin specific, highlighting the importance of precise diagnosis. The goal of this study is to identify the genetic causes of pediatric cardiomyopathy. Rapid, comprehensive and cost-effective detection of genetic causes of cardiomyopathy will aid management and development of novel treatment strategies.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * Subjects with cardiomyopathy * Family members of subjects with cardiomyopathy Exclusion Criteria: * Subjects without cardiomyopathy * Family members of subjects without cardiomyopathy

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

CardiomyopathiesDilated CardiomyopathyHypertrophic CardiomyopathyRestrictive CardiomyopathyArrhythmogenic Right Ventricular CardiomyopathyLeft Ventricular Non-compaction Cardiomyopathy

Locations

IU School of Medicine

Indianapolis, Indiana 46202

United States